Cytomol Labs

What Cytomol Labs does

Cytomol Labs is a Hyderabad-based, privately held diagnostic services provider founded in 2015. According to its firmographic record, the company offers investigative services across four specialty areas: pathology, biochemistry, cytogenetics, and molecular diagnostics. This positioning places it in the Indian clinical and specialty diagnostics segment, where it would typically serve a mix of hospital referrals, clinic partners, and walk-in patients requiring routine and advanced laboratory testing.

The company operates with a small workforce of 11–50 employees per available firmographics and maintains a web presence at cytomol.in. However, the accessible website consists only of a brand tagline ("Innovating Health Through Biology"), a contact prompt, and a copyright notice — no service catalog, test menu, pricing, accreditations, leadership information, customer references, or technology disclosures are published. There is no public information on its underlying laboratory technology, assay portfolio, instrumentation, quality certifications (e.g., NABL/CAP), or proprietary platforms.

No business model mechanics are disclosed: pricing model, go-to-market approach, reimbursement pathways, channel structure, and revenue mix are all absent from the source data. There is no disclosed funding history, investor base, ownership structure, or financial reporting. The aggregate information available suggests a small, privately operated specialty diagnostics laboratory with a minimal public footprint and significant unverified claims — any investment diligence would require direct engagement with the company to validate operating status, test menu, certifications, and commercial traction.

Name

Cytomol Labs

Website

https://cytomol.in

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Cytomol Labs is a Hyderabad-based diagnostic services provider founded in 2015, offering investigative testing across pathology, biochemistry, cytogenetics, and molecular diagnostics to clinical and specialty testing customers in India.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industries

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Flow Cytometry & Cellular Analysis Diagnostics (HLAHAAAF), Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Pathology laboratory services
• Molecular diagnostics testing
• Cytogenetics analysis services
• Biochemistry testing services
• Clinical diagnostic investigations

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Core offering

Cytomol Labs offers investigative diagnostic services across four core laboratory disciplines: pathology, biochemistry, cytogenetics, and molecular diagnostics. The company operates as a clinical diagnostic laboratory providing specialized testing and analysis of biological samples for referring clinicians, healthcare facilities, and patients in India.

Product overview

No detailed product or service information is available in the provided source content.

Differentiator

Problem solved

Functional benefit

Products and services

• Pathology Investigative Services Diagnostic pathology investigations including analysis of tissue, blood, and other biological samples to support disease diagnosis for referring clinicians and patients.
• Biochemistry Investigative Services Clinical biochemistry testing services measuring biochemical markers in patient samples to support diagnosis and monitoring of metabolic and organ function disorders.
• Cytogenetics Investigative Services Cytogenetics analysis services including chromosomal studies and karyotyping to support diagnosis of genetic disorders and hematological conditions.
• Molecular Diagnostics Investigative Services Molecular diagnostics testing services using molecular biology techniques such as PCR and DNA/RNA analysis to detect genetic, infectious, and oncological conditions.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Broad incumbents

• Apollo Diagnostics: Diagnostic arm of Apollo Hospitals, offering pathology, biochemistry, and advanced diagnostics across India. Comparable to Cytomol Labs in core lab services, with broader hospital integration and stronger consumer brand as part of the Apollo healthcare ecosystem.
• Tata 1mg Labs (1mg Technologies): Digital-first consumer diagnostics and pharmacy platform that has expanded into pathology and biochemistry testing via partnered labs and its own facilities. Comparable to Cytomol Labs in routine test categories, competing on digital ordering convenience and pan-India home collection.

Direct peers

• Metropolis Healthcare: Pan-India multi-disciplinary diagnostic chain providing pathology, biochemistry, cytogenetics, and advanced molecular testing. Directly comparable service portfolio and B2B referral model to Cytomol Labs, with greater geographic reach and brand recognition.
• Dr. Lal PathLabs: India's largest diagnostic chain offering pathology, biochemistry, cytogenetics, and molecular diagnostics through a national collection network. Closest direct competitor to Cytomol Labs in service mix, with the difference being pan-India scale versus Cytomol's regional Hyderabad footprint.
• Oncquest Laboratories: India-focused diagnostics lab with deep specialization in molecular diagnostics, cytogenetics, and cancer pathology. Directly comparable to Cytomol Labs in advanced diagnostics offerings, particularly the molecular and cytogenetics lines.
• MedGenome: India and US-headquartered molecular diagnostics and genomics company offering cytogenetics, molecular pathology, and genetic testing. Comparable to Cytomol Labs specifically in the molecular diagnostics and cytogenetics specialties, with deeper genomics expertise.
• SRL Diagnostics (Agilus Diagnostics): One of India's largest reference laboratory networks offering the full spectrum of pathology, biochemistry, cytogenetics, and molecular diagnostics. Comparable in service scope to Cytomol Labs, with significantly larger institutional and hospital contract base.
• Strand Life Sciences: India-based genomics and molecular diagnostics company offering cytogenetics, molecular pathology, and clinical genomics services. Most directly comparable peer to Cytomol Labs on the molecular diagnostics and cytogenetics side of the portfolio.
• Thyrocare Technologies: High-volume, low-cost Indian diagnostic laboratory offering pathology and biochemistry through a hub-and-spoke model. Directly comparable in routine clinical chemistry and immunoassay testing, competing on price and turnaround time rather than molecular specialization.
• Neuberg Diagnostics: Pan-India diagnostic chain with strong presence in South India including Hyderabad, offering pathology, biochemistry, cytogenetics, and molecular diagnostics. A direct regional competitor with comparable multi-disciplinary capabilities and stronger brand penetration in Cytomol's home market.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights3 records

Customer concentration

• Xx.com/Cytomollabs
• Facebookfacebook.com/cytomol
• LinkedInlinkedin.com/company/cytomol

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cytomol Labs